Stock DNA
Other Agricultural Products
INR 22 Cr (Micro Cap)
NA (Loss Making)
40
0.00%
0.68
-7.76%
2.65
Total Returns (Price + Dividend) 
Hamps Bio for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Unaudited Financial Result For Half Year Ended 30.09.2026
06-Nov-2026 | Source : BSEUnaudited financial result for half year ended 30.09.2026 is attached herewith.
Board Meeting Outcome for BOARD MEETING OUTCOME
06-Nov-2026 | Source : BSEBoard meeting outcome for approval of Unaudited Financial Result for the half year ended 30.09.2026
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Half Year Ended On September 30 2026.
03-Nov-2026 | Source : BSEHamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 inter alia to consider and approve the Unaudited Standalone And Consolidated Financial Results of The Company for the Half Year Ended On September 30 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
Hamps Bio Limited has announced 1:1 bonus issue, ex-date: 08 Sep 25
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Herrik Mountbaton Shah (31.12%)
None
25.34%
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 27.48% vs -11.58% in Mar 2025
Growth in half year ended Sep 2025 is -766.67% vs -88.89% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 2.93% vs 16.13% in Mar 2024
YoY Growth in year ended Mar 2025 is -40.00% vs 38.89% in Mar 2024